Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Ligand Pharm (NQ: LGND ) 102.38 +0.93 (+0.91%) Streaming Delayed Price Updated: 1:38 PM EDT, Jul 23, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Press Releases about Ligand Pharm < Previous 1 2 3 Next > Ligand Pharmaceuticals Appoints Jason Haas to its Board of Directors June 29, 2022 From Ligand Pharmaceuticals Incorporated Via Business Wire Ligand Reports First Quarter 2022 Financial Results May 04, 2022 From Ligand Pharmaceuticals Incorporated Via Business Wire Ligand to Report First Quarter Financial Results on May 4 April 19, 2022 From Ligand Pharmaceuticals Incorporated Via Business Wire Ligand Pharmaceuticals Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) April 08, 2022 From Ligand Pharmaceuticals Incorporated Via Business Wire Ligand to Spin-Off its OmniAb Business Through Merger with Avista Public Acquisition Corp. II March 23, 2022 From Ligand Pharmaceuticals Incorporated Via Business Wire Ligand Reports Fourth Quarter and Full Year 2021 Financial Results February 17, 2022 From Ligand Pharmaceuticals Incorporated Via Business Wire Ligand to Report Fourth Quarter Financial Results on February 17 February 09, 2022 From Ligand Pharmaceuticals Incorporated Via Business Wire Ligand’s Partner CStone Pharmaceuticals Receives Approval in China for Sugemalimab (Cejemly®) for the First-Line Treatment of Advanced Non-Small Cell Lung Cancer in Combination with Chemotherapy December 22, 2021 From Ligand Pharmaceuticals Incorporated Via Business Wire Ligand and GSK Expand Global Collaboration and License Agreement December 21, 2021 From Ligand Pharmaceuticals Incorporated Via Business Wire Ligand Reports Third Quarter 2021 Financial Results November 09, 2021 From Ligand Pharmaceuticals Incorporated Via Business Wire Ligand Pursuing Plans for OmniAb to Become a Standalone Public Company November 09, 2021 From Ligand Pharmaceuticals Incorporated Via Business Wire Ligand to Report Third Quarter Financial Results on November 9, 2021 October 26, 2021 From Ligand Pharmaceuticals Incorporated Via Business Wire Ligand and CR Double-Crane Enter Collaboration Agreement to Develop an Oral COVID-19 Therapeutic Using Ligand’s BEPro Technology™ October 21, 2021 From Ligand Pharmaceuticals Incorporated Via Business Wire Ligand’s Partner Gloria Biosciences Receives Approval in China for Zimberelimab for the Treatment of Recurrent or Refractory Classical Hodgkin’s Lymphoma August 30, 2021 From Ligand Pharmaceuticals Incorporated Via Business Wire Ligand Partner Travere Therapeutics Announces Positive Topline Interim Results from the Ongoing Phase 3 PROTECT Study of Sparsentan in IgA Nephropathy August 16, 2021 From Ligand Pharmaceuticals Via Business Wire Ligand Reports Second Quarter 2021 Financial Results July 29, 2021 From Ligand Pharmaceuticals Incorporated Via Business Wire Ligand Partner Jazz Pharmaceuticals Launches RYLAZE™ (asparaginase erwinia chrysanthemi (recombinant)-rywn), Formerly JZP458 July 21, 2021 From Ligand Pharmaceuticals Incorporated Via Business Wire Ligand’s Partner Merck Receives FDA Approval for VAXNEUVANCE™ for the Prevention of Invasive Pneumococcal Disease in Adults Caused by 15 Serotypes July 19, 2021 From Ligand Pharmaceuticals Incorporated Via Business Wire Ligand to Report Second Quarter Financial Results on July 29, 2021 July 16, 2021 From Ligand Pharmaceuticals Incorporated Via Business Wire Ligand Pharmaceuticals Appoints Dr. Jennifer Cochran to its Board of Directors July 14, 2021 From Ligand Pharmaceuticals Incorporated Via Business Wire Ligand Reports First Quarter 2021 Financial Results May 03, 2021 From Ligand Pharmaceuticals Incorporated Via Business Wire Ligand to Report First Quarter Financial Results on May 3, 2021 April 22, 2021 From Ligand Pharmaceuticals Incorporated Via Business Wire < Previous 1 2 3 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.